Related Experiment Video
Updated: Aug 9, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Electrolyte Disorders Associated with Piperacillin/Tazobactam: A Pharmacovigilance Study Using the FAERS Database.
Heenam Seo1,2, Eunyoung Kim2,3,4
1Department of Pharmacy, Kangbuk Samsung Hospital, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Republic of Korea.
Piperacillin-tazobactam (TZP), a common antibiotic, is significantly linked to hypokalemia, a dangerous electrolyte disorder. This finding highlights a potential risk associated with TZP use in patients.
Area of Science:
- Pharmacovigilance
- Clinical Pharmacology
- Internal Medicine
Background:
- Electrolyte disorders (EDs) pose significant health risks.
- Piperacillin-tazobactam (TZP) is a frequently prescribed antibiotic for serious infections.
Purpose of the Study:
- To investigate the potential association between piperacillin-tazobactam (TZP) and electrolyte imbalances.
- To identify specific electrolyte disorders linked to TZP use.
Main Methods:
- A disproportionality analysis was performed on the US FDA Adverse Event Reporting System (FAERS) database from 2004 to 2018.
- Data mining indices including PRR, ROR, and IC were calculated to detect adverse event signals for TZP.
- Further analyses compared TZP to other penicillins.
Main Results:
- A total of 9829 reports related to TZP were analyzed.
- Hypokalemia was identified as the only significant electrolyte disorder signal associated with TZP compared to all other drugs.
- Hypokalemia remained a significant signal for TZP when compared to other penicillins.
Conclusions:
- Piperacillin-tazobactam (TZP) is significantly associated with the development of hypokalemia.
- This association warrants clinical consideration, especially in patients at risk for electrolyte disturbances.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Pyelonephritis II: Diagnostic Studies and Management

